furosemide has been researched along with fluorodeoxyglucose f18 in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (18.75) | 18.2507 |
2000's | 7 (43.75) | 29.6817 |
2010's | 6 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adler, LP; Faulhaber, PF; Leisure, GP; Miraldi, F; O'Donnell, JK; Vesselle, HJ | 1 |
Fisher, S; Kosuda, S; Wahl, RL | 1 |
Adler, LP; Faulhaber, PF; Leisure, GP; Miraldi, F; Vesselle, H | 1 |
Liu, IJ; Nino-Murcia, M; Segall, GM; Terris, MK | 1 |
Diehl, M; Döbert, N; Grünwald, F; Kranert, T; Manolopoulou, M; Menzel, C; Risse, J | 1 |
Basu, S; Nair, N | 1 |
Castaldo, S; Delaloye, AB; Delaloye, JF; Jichlinski, P; Kamel, EM; Leisinger, HJ; Malterre, J; Meuwly, JY; Prior, JO; Vaucher, L | 1 |
García-Garzón, JR; Lomeña, F; López-Gandul, S; Pérez-Moure, G; Simó-Perdigó, M; Soler-Peter, M | 1 |
Blaufox, MD; Freeman, LM | 1 |
Huang, SS; Tu, DG; Wang, KB | 1 |
Demeter, SJ; Ducharme, J; Leslie, WD; Nijjar, S; Patterson, J | 1 |
Beck, T; Grosu, AL; Jilg, CA; Meyer, PT; Rischke, HC; Schultze-Seemann, W; Vach, W; Wieser, G | 1 |
d'Amico, A; Di Pietro, M; Gorczewska, I; Gorczewski, K; Turska-d'Amico, M | 1 |
Balar, AV; Friedman, KP; Huang, WC; Jackson, K; Ponzo, F; Raad, RA; Rosenkrantz, AB | 1 |
Brillouet, S; Caselles, O; Chaltiel, L; Courbon, F; Dercle, L; Dierickx, LO; Zerdoud, S | 1 |
Cussó, L; Desco, M | 1 |
2 trial(s) available for furosemide and fluorodeoxyglucose f18
Article | Year |
---|---|
Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of transitional cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Diuretics; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Urinary Bladder Neoplasms | 2003 |
The effect of furosemide dose timing on bladder activity in oncology imaging with 18F-fluorodeoxyglucose PET/CT.
Topics: Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Image Interpretation, Computer-Assisted; Liver; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms | 2010 |
14 other study(ies) available for furosemide and fluorodeoxyglucose f18
Article | Year |
---|---|
Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis.
Topics: Abdominal Neoplasms; Adolescent; Aged; Artifacts; Catheterization; Constriction; Deoxyglucose; Diuretics; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Furosemide; Humans; Image Enhancement; Infusions, Intravenous; Kidney; Male; Middle Aged; Pelvic Neoplasms; Radiopharmaceuticals; Sodium Chloride; Tomography, Emission-Computed; Ureter; Urinary Bladder; Urinary Catheterization; Urinary Tract; Water-Electrolyte Balance | 1997 |
Animal studies on the reduction and/or dilution of 2-deoxy-2-[18F]fluoro-D-glucose (FDG) activity in the urinary system.
Topics: Animals; Diuretics; Drug Interactions; Female; Fluorodeoxyglucose F18; Furosemide; Kidney; Lysine; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed; Urinary Tract | 1997 |
Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer.
Topics: Abdomen; Administration, Intravesical; Artifacts; Catheterization; Colon; Colonic Neoplasms; Diuretics; Fluid Therapy; Fluorodeoxyglucose F18; Furosemide; Humans; Image Enhancement; Injections, Intravenous; Kidney; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Radiopharmaceuticals; Rectal Neoplasms; Sodium Chloride; Therapeutic Irrigation; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ureter; Urinary Bladder; Urinary Catheterization; Urinary Tract | 1998 |
Urinary fluorine-18 fluorodeoxyglucose excretion with and without intravenous application of furosemide.
Topics: Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Selected cases demonstrating the value of furosemide-primed 18F-FDG PET in identifying adrenal involvement.
Topics: Adenocarcinoma; Adolescent; Adrenal Gland Neoplasms; Child, Preschool; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Infant; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies.
Topics: Adult; Diuresis; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Middle Aged; Neoplasm Staging; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2006 |
Intravenous furosemide injection during 18F-FDG PET acquisition.
Topics: Abdominal Neoplasms; Diuretics; Drug Combinations; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Image Enhancement; Injections, Intravenous; Male; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Seminars in Nuclear Medicine. Selected pharmacologic interventions and monitoring. Letter from the editors.
Topics: Fluorodeoxyglucose F18; Furosemide; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
The identification of a tumor of the cervix on PET/CT with bladder filling and emptying.
Topics: Carcinoma, Squamous Cell; Diuresis; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder; Uterine Cervical Neoplasms; Whole Body Imaging | 2009 |
Furosemide diminishes ¹⁸F-fluoroethylcholine uptake in prostate cancer in vivo.
Topics: Aged; Biological Transport; Choline; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Neoplasm Metastasis; Organ Specificity; Prostatic Neoplasms; Quality Control; Radionuclide Imaging; Retrospective Studies; Urinary Tract; Urography | 2014 |
Effect of furosemide administration before F-18 fluorodeoxyglucose positron emission tomography/computed tomography on urine radioactivity and detection of uterine cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Furosemide; Humans; Multimodal Imaging; Positron-Emission Tomography; Radioactivity; Retrospective Studies; Tomography, X-Ray Computed; Urine; Uterine Cervical Neoplasms | 2014 |
Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.
Topics: Aged; Carcinoma, Transitional Cell; Diuresis; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvis; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2017 |
Evaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancer.
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Young Adult | 2019 |
Suppression of 18F-FDG signal in the bladder on small animal PET-CT.
Topics: Animals; Diuretics; Fluorodeoxyglucose F18; Furosemide; Mice; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urinary Bladder | 2018 |